East Asia & Pacific vs Guyana: Prevalence of anemia among women of reproductive age
East Asia & Pacific
18.7%
in 2023
Guyana
37.5%
in 2023
East Asia & Pacific rank
41st
Guyana rank
38th
Prevalence of anemia among women of reproductive age over time
- East Asia & Pacific
- Guyana
How they compare
Guyana currently reports 37.5% against 18.7% in East Asia & Pacific, a difference of 18.8%.
That makes Guyana's figure about 2.0 times East Asia & Pacific's.
Across all 24 years both countries report, Guyana has been ahead every year.
East Asia & Pacific ranks 41st and Guyana ranks 38th of 47 groups.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | East Asia & Pacific | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.2% | 42.3% | 21.1% | Guyana |
| 2010s | 18.5% | 37.3% | 18.8% | Guyana |
| 2020s | 18.3% | 37.2% | 18.9% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, East Asia & Pacific or Guyana?
- Guyana, at 37.5% against 18.7% in East Asia & Pacific as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between East Asia & Pacific and Guyana?
- 18.8%, with Guyana ahead.
- How many years of comparable data are there for East Asia & Pacific and Guyana?
- 24 years are reported by both, from 2000 to 2023.
- How do East Asia & Pacific and Guyana rank globally for prevalence of anemia among women of reproductive age?
- East Asia & Pacific ranks 41st and Guyana ranks 38th of 47 groups.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.